Antineoplastics, EGFR Inhibitor Antineoplastics, EGFR Inhibitor afatinib Caprelsa cetuximab Erbitux erlotinib gefitinib Gilotrif Iressa necitumumab osimertinib panitumumab Portrazza rociletinib Tagrisso Tarceva vandetanib Vectibix